Literature DB >> 7083639

Endotoxin induced 'tumour-necrosis serum' kills a subpopulation of normal lymphocytes in vitro.

J H Playfair, J B de Souza, J Taverne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7083639      PMCID： PMC1536412     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  Subclasses of T cells with different sensitivities to cytotoxic antibody in the presence of anesthetics.

Authors:  S K Lee; J Singh; R B Taylor
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

Review 2.  Induction and immunological properties of tumor necrosis factor.

Authors:  M K Hoffmann; H F Oettgen; L J Old; R S Mittler; U Hammerling
Journal:  J Reticuloendothel Soc       Date:  1978-04

3.  Human fetal thymus and bone marrow contain target cells for natural killer cells.

Authors:  M Hansson; R Kiessling; B Andersson
Journal:  Eur J Immunol       Date:  1981-01       Impact factor: 5.532

4.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 5.  Lymphotoxin. A review and analysis.

Authors:  W Rosenau; C D Tsoukas
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

6.  Purification and physico-chemical characterization of rabbit tumor necrosis factor.

Authors:  M R Ruff; G E Gifford
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

7.  Rabbit tumor necrosis factor: mechanism of action.

Authors:  M R Ruff; G E Gifford
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Endotoxin-induced serum factor kills malarial parasites in vitro.

Authors:  J Taverne; H M Dockrell; J H Playfair
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

9.  Increased hepatotoxicity of bacterial lipopolysaccharide in mice infected with Schistosoma mansoni.

Authors:  J Ferluga; M J Doenhoff; A C Allison
Journal:  Parasite Immunol       Date:  1979       Impact factor: 2.280

10.  Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties.

Authors:  N Matthews; J F Watkins
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640
  10 in total
  7 in total

1.  Phase I study of recombinant human tumor necrosis factor.

Authors:  K Kimura; T Taguchi; I Urushizaki; R Ohno; O Abe; H Furue; T Hattori; H Ichihashi; K Inoguchi; H Majima
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.

Authors:  J Taverne; N Matthews; P Depledge; J H Playfair
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

3.  Tumor necrosis factor: recent advances.

Authors:  R Munker; H P Koeffler
Journal:  Klin Wochenschr       Date:  1987-04-15

4.  Necrosin: purification and properties of a cytotoxin derived from a murine macrophage-like cell line.

Authors:  F C Kull; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.

Authors:  F C Kull; S Jacobs; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

6.  Anti-tumour cytotoxin from macrophages: no correlation between cytotoxin adsorption by tumour cell lines and their cytotoxin susceptibility.

Authors:  N Matthews
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

7.  Tumour necrosis factor in man: clinical and biological observations.

Authors:  P Selby; S Hobbs; C Viner; E Jackson; A Jones; D Newell; A H Calvert; T McElwain; K Fearon; J Humphreys
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.